Xu L - Search Results

1

Heat shock factor 1 directly regulates transsulfuration pathway to promote prostate cancer proliferation and survival.

Hauck JS, Moon D, Jiang X, Wang ME, Zhao Y, Xu L, Quang H, Butler W, Chen M, Macias E, Gao X, He Y, Huang J. Hauck JS, et al. Among authors: xu l. Commun Biol. 2024 Jan 3;7(1):9. doi: 10.1038/s42003-023-05727-9. Commun Biol. 2024. PMID: 38172561 Free PMC article.

2

ATM deficiency promotes progression of CRPC by enhancing Warburg effect.

Xu L, Ma E, Zeng T, Zhao R, Tao Y, Chen X, Groth J, Liang C, Hu H, Huang J. Xu L, et al. Endocr Relat Cancer. 2019 Jan 1;26(1):59-71. doi: 10.1530/ERC-18-0196. Endocr Relat Cancer. 2019. PMID: 30400006 Free PMC article.

3

N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway.

Yin Y, Xu L, Chang Y, Zeng T, Chen X, Wang A, Groth J, Foo WC, Liang C, Hu H, Huang J. Yin Y, et al. Among authors: xu l. Mol Cancer. 2019 Jan 18;18(1):11. doi: 10.1186/s12943-019-0941-2. Mol Cancer. 2019. PMID: 30657058 Free PMC article.

4

Targeting androgen receptor-independent pathways in therapy-resistant prostate cancer.

Xu L, Chen J, Liu W, Liang C, Hu H, Huang J. Xu L, et al. Asian J Urol. 2019 Jan;6(1):91-98. doi: 10.1016/j.ajur.2018.11.002. Epub 2018 Nov 28. Asian J Urol. 2019. PMID: 30775252 Free PMC article. Review.

5

Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway.

Yin Y, Xu L, Chang Y, Zeng T, Chen X, Wang A, Groth J, Foo WC, Liang C, Hu H, Huang J. Yin Y, et al. Among authors: xu l. Mol Cancer. 2019 Jun 19;18(1):107. doi: 10.1186/s12943-019-1034-y. Mol Cancer. 2019. PMID: 31217018 Free PMC article.

6

Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC.

Zhang Y, Xu L, Chang Y, Li Y, Butler W, Jin E, Wang A, Tao Y, Chen X, Liang C, Huang J. Zhang Y, et al. Among authors: xu l. Prostate Cancer Prostatic Dis. 2020 Mar;23(1):160-171. doi: 10.1038/s41391-019-0172-z. Epub 2019 Aug 30. Prostate Cancer Prostatic Dis. 2020. PMID: 31471556 Free PMC article.

7

Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer.

Li Y, He Y, Butler W, Xu L, Chang Y, Lei K, Zhang H, Zhou Y, Gao AC, Zhang Q, Taylor DG, Cheng D, Farber-Katz S, Karam R, Landrith T, Li B, Wu S, Hsuan V, Yang Q, Hu H, Chen X, Flowers M, McCall SJ, Lee JK, Smith BA, Park JW, Goldstein AS, Witte ON, Wang Q, Rettig MB, Armstrong AJ, Cheng Q, Huang J. Li Y, et al. Among authors: xu l. Sci Transl Med. 2019 Dec 4;11(521):eaax0428. doi: 10.1126/scitranslmed.aax0428. Sci Transl Med. 2019. PMID: 31801883 Free PMC article.

8

A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer.

Xu L, Yin Y, Li Y, Chen X, Chang Y, Zhang H, Liu J, Beasley J, McCaw P, Zhang H, Young S, Groth J, Wang Q, Locasale JW, Gao X, Tang DG, Dong X, He Y, George D, Hu H, Huang J. Xu L, et al. Proc Natl Acad Sci U S A. 2021 Mar 30;118(13):e2012748118. doi: 10.1073/pnas.2012748118. Proc Natl Acad Sci U S A. 2021. PMID: 33753479 Free PMC article.

9

Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2/4-PFKP during tumorigenesis of advanced prostate cancer.

Xu C, Tsai YH, Galbo PM, Gong W, Storey AJ, Xu Y, Byrum SD, Xu L, Whang YE, Parker JS, Mackintosh SG, Edmondson RD, Tackett AJ, Huang J, Zheng D, Earp HS, Wang GG, Cai L. Xu C, et al. Among authors: xu l, xu y. Nucleic Acids Res. 2021 May 21;49(9):4971-4988. doi: 10.1093/nar/gkab252. Nucleic Acids Res. 2021. PMID: 33849067 Free PMC article.

10

Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestry.

Patierno BM, Foo WC, Allen T, Somarelli JA, Ware KE, Gupta S, Wise S, Wise JP Sr, Qin X, Zhang D, Xu L, Li Y, Chen X, Inman BA, McCall SJ, Huang J, Kittles RA, Owzar K, Gregory S, Armstrong AJ, George DJ, Patierno SR, Hsu DS, Freedman JA. Patierno BM, et al. Among authors: xu l. Prostate Cancer Prostatic Dis. 2022 Sep;25(3):513-523. doi: 10.1038/s41391-021-00460-y. Epub 2021 Oct 13. Prostate Cancer Prostatic Dis. 2022. PMID: 34645983 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38,954 results

Search Page